Efficacy and Safety Study of Tafenoquine (TQ) Co-administered With Dihydroartemisinin-piperaquine (DHA-PQP) for the Radical Cure of Plasmodium Vivax (P. Vivax) Malaria
Clinical trial NCT02802501 · COMPLETED
Trial details
- NCT number
- NCT02802501
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-08
- Primary completion
- 2019-08-19
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.